⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked sharesUnlock shares

CLSA reaffirms Outperform on Apollo Hospitals stock amid growth across segments

EditorEmilio Ghigini
Published 14/11/2024, 07:50
APLH
-

On Thursday, Apollo Hospitals (NS:APLH) (APHS:IN) stock maintained its Outperform (2) rating with a steady price target of INR 8,400.00, as confirmed by CLSA.

The firm highlighted the company's aggressive expansion strategy, which includes increasing hospital bed capacity by 28% and targeting a 50% growth in Gross Merchandise Value (GMV) for its online pharmacy by the fiscal year 2025.

Additionally, Apollo Hospitals aims for a 19% growth in its offline pharmacy business and expects to surpass the industry growth rate in the diagnostics segment.

The expansion efforts of Apollo Hospitals, India's largest integrated healthcare service provider, are set to capitalize on favorable market conditions. CLSA predicts that these initiatives will likely result in margin and earnings growth for the company between the fiscal years 2025 and 2027.

The firm's analysis suggests that the comprehensive growth strategy being employed by Apollo Hospitals is well-positioned to yield positive financial outcomes in the coming years.

The financial institution's confidence in Apollo Hospitals is reflected in its decision to reiterate the Outperform rating. The valuation is supported by a Discounted Cash Flow (DCF) analysis, which reinforces the INR 8,400.00 price target. This target remains unchanged, indicating the firm's steady faith in the healthcare provider's potential for sustained growth and profitability.

In its commentary, CLSA cited the company's plans to expand its hospital network and enhance its online and offline pharmacy operations. These steps are integral to Apollo Hospitals' broader ambition to not only expand its service offerings but also to deliver superior growth in comparison to the overall industry.

The report from CLSA concludes by reaffirming the Outperform rating and the DCF-based price target of INR 8,400.00 for Apollo Hospitals. This projection underscores the firm's anticipation of the healthcare provider's successful execution of its expansion strategy and the resultant financial benefits over the next few fiscal years.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.